Linker-Free PROTACs: Definition, Design Logic, and Development Challenges

* Please be kindly noted that our services and products can only be used for research to organizations or companies and not intended for any clinical or individuals.

Consult with Our Experts

What Are Linker-Free PROTACs?

Structural Definition: Direct Degron-to-Warhead Conjugation

A linker-free PROTAC is a small-molecule degrader in which a single amino acid is covalently attached, without any spacer, to a target-binding warhead. The amino acid is typically coupled through its carboxyl group to a functionalized position on the warhead, forming an amide bond. Critically, the amino acid's α-amino group remains free: once conjugated, it becomes the new N-terminus of the whole molecule, and it is this exposed N-terminal residue that serves as the E3-recruiting element. In other words, the amino acid is not an inert decoration—it is the degron itself, and the architecture deliberately borrows the logic of natural protein degradation signals.

The concept emerged from work on amino acid-based targeted chimeras (AATacs), which first used Gly, Pro, and Lys residues—coupled through short PEG linkers to the ALK inhibitor brigatinib—to recruit the E3 ligases CRL2^ZYG11B/ZER1, GID4, and UBR family proteins, respectively. The linker-free generation went one step further by removing the PEG spacer entirely. The flagship example, Pro-BA, connects L-proline directly to the dimethylamine handle of a brigatinib analog. The molecule is only one amino acid heavier than the parent inhibitor, whereas conventional PROTACs commonly weigh 700–1100 Da because of their linker plus E3-ligand payload.

It helps to place linker-free PROTACs on the spectrum of degradation modalities. At one end sit conventional bifunctional PROTACs, with their three-module architecture and well-developed CRBN/VHL recruitment chemistry. At the other end sit molecular glues—small molecules that create or stabilize a degradation interface without any separate recruiting ligand. Linker-free PROTACs occupy a distinctive middle ground: they remain warhead-driven and therefore target-directed, but they use nature's own degradation signals, amino acid degrons, as their E3-recruitment module. Compared with other alternative PROTAC technologies, this approach keeps molecular size close to that of the parent inhibitor while preserving the modular logic that makes PROTAC design tractable.

Why Remove the Linker? The Rationale Behind Linker-Free Design

The first rationale is molecular weight. Conventional PROTACs routinely exceed the property limits that medicinal chemists associate with good permeability and oral exposure. High molecular weight, high polar surface area, and high hydrogen-bond counts translate into poor solubility, slow cell entry, and difficult formulation. A linker-free design removes several hundred daltons at a stroke, giving the degrader a physicochemical starting point much closer to that of an ordinary inhibitor.

The second rationale is synthetic and optimization economics. Linker optimization is a combinatorial burden: PEG versus alkyl versus rigid motifs, lengths from two atoms to more than ten, multiple attachment points on both ligands. Each combination requires synthesis, purification, and testing, and even dedicated linker design and optimization campaigns cannot guarantee that a productive geometry exists for every target. A linker-free molecule collapses this design space. One conjugation step attaches the degron, and the remaining optimization variables—attachment site, degron identity, stereochemistry—form a small, systematic matrix that a project can actually enumerate.

The third rationale is empirical and, to many researchers, surprising: removing the linker can make the degrader better, not worse. In direct comparisons, linker-free Pro-BA degraded the EML4-ALK fusion protein with a DC₅₀ of 74 nM in H3122 lung cancer cells, whereas the best linker-bearing analog, Pro-PEG3-BA, showed a DC₅₀ of 416 nM. Pro-BA also outperformed Pro-PEG1-BA and Pro-PEG3-BA in blocking cell growth. The advantages carried through to physicochemical behavior: Pro-BA was more water-soluble than Pro-PEG3-BA (approximately 1.8×10⁶ μM versus 8.6×10⁵ μM) and reached an intracellular concentration roughly 1.5-fold higher. In a xenograft model of H3122 cells, Pro-BA suppressed tumor growth more effectively than both Pro-PEG3-BA and brigatinib itself, while brigatinib, as a kinase inhibitor, left EML4-ALK protein levels unchanged—a clean demonstration of the mechanistic difference between inhibiting and degrading a target.

Table 1. Linker-Free PROTACs Compared with Conventional PROTACs and Molecular Glues.

The comparison in Table 1 also clarifies what a linker-free PROTAC is not. It is not a molecular glue, because target binding is still driven by a defined warhead rather than by a fortuitous glue-like interface. And it is not simply a truncated PROTAC, because the E3-recruitment mechanism—recognition of an N-terminal residue—is fundamentally different from the binding-pocket logic of CRBN and VHL ligands. That difference in mechanism is what makes the strategy worth understanding on its own terms.

How Do Linker-Free PROTACs Trigger Target Protein Degradation?

N-Degron Recognition by N-Recognin E3 Ligases

The mechanistic foundation of linker-free PROTACs is the N-end rule pathway, one of the oldest and best-characterized branches of the ubiquitin-proteasome system. The N-end rule states that the identity of a protein's N-terminal residue strongly influences its lifetime. An N-degron consists of the N-terminal residue together with neighboring features, including lysine residues positioned to receive ubiquitin chains. Specialized E3 ligases called N-recognins read these signals and commit the modified protein to proteasomal destruction.

The classical pathway, characterized in depth in yeast and mammals, divides destabilizing residues into two groups: type 1 basic residues (Arg, Lys, His) and type 2 bulky hydrophobic residues (Phe, Trp, Tyr, Leu, Ile), both recognized by UBR-box-containing N-recognins. Later work expanded the map considerably. N-terminal proline was identified as a degradation signal recognized by GID4, the substrate receptor of the CTLH E3 ligase complex, and N-terminal glycine was revealed as a potent degron recognized redundantly by two CRL2 complexes built on the related substrate adaptors ZYG11B and ZER1. Amino acids that used to be considered neutral stabilizing residues turned out to be active signals in the right structural context.

A linker-free PROTAC exploits this system by artificial installation. When Pro-BA binds EML4-ALK through its brigatinib-derived warhead, the molecule presents a free N-terminal proline to the cellular degradation machinery. GID4 recognizes that proline, the CTLH complex assembles on the target, and the fusion protein is ubiquitinated and destroyed. The degrader itself is released after each degradation event and can act catalytically, in the same sub-stoichiometric, event-driven sense as conventional PROTACs.

Matching Amino Acid Degrons to E3 Ligase Systems

Because each amino acid points to a specific N-recognin, degron choice is effectively E3 choice. The experimentally validated pairings are concrete and instructive:

• Proline → GID4/CTLH. The proline degron has produced the most potent linker-free degraders reported to date. Pro-BA degrades EML4-ALK with a DC₅₀ of 74 nM and reaches 82% degradation at 500 nM in H3122 cells.
• Glycine → CRL2^ZYG11B/ZER1. Gly-BA also degrades EML4-ALK efficiently (DC₅₀ of 142 nM), with an interesting kinetic signature: degradation begins within about 30 minutes, faster than Pro-BA, but the overall clearance half-time is slower.
• Lysine and arginine → UBR family. These basic degrons recruit UBR-type N-recognins. Directly conjugated Arg-BA required concentrations near 10 μM to show an effect, and Lys-based AATacs were the weakest of the three PEG-linked amino acids tested (DC₅₀ of 1.32 μM for Lys-PEG3-BA). Basic N-degrons appear to depend more heavily on downstream sequence context than Pro or Gly.

This structure of the design space enables a tactic that researchers have begun to call degron switching: keeping the warhead constant and changing only the amino acid to reroute degradation through a different E3 ligase. Switching can be used to tune degradation depth, to adapt to cell types that express one N-recognin more strongly than another, or to build mechanistic controls. The same logic that makes amino acid degrons interchangeable also makes them informative—a panel of degron variants quickly reveals which N-end rule branch a given target can productively engage.

From Direct Conjugation to Ubiquitination and Proteasomal Degradation

The full degradation cycle for a linker-free PROTAC proceeds through five steps. First, the warhead binds its target protein. Second, the N-terminal degron is recognized by the matching N-recognin, for example GID4 in the CTLH complex. Third, the E3 ligase complex docks onto the target, positioning its ubiquitin-transfer machinery near lysine residues on the target surface. Fourth, polyubiquitin chains are assembled on those lysines. Fifth, the 26S proteasome recognizes the ubiquitin signal, unfolds and destroys the target, and the degrader is released to catalyze another round.

Design Logic of Linker-Free PROTACs

Linker-free PROTAC design is best treated as a constrained geometry problem. Because the molecule cannot use a long spacer to explore many relative protein orientations, success depends on selecting a target ligand and attachment point that naturally position the degron toward a compatible E3-recognition surface. This makes structural analysis, matched analog design, and early mechanistic testing particularly valuable.

Warhead Selection and Exit Vector Geometry

The warhead must satisfy two requirements at the same time. First, it should bind the protein of interest strongly enough to maintain useful target engagement after chemical modification. Second, it must offer an attachment position that points away from essential target-binding interactions and remains accessible to solvent. A potent inhibitor with no suitable exit vector can be a poor starting point for a linker-free degrader.

Co-crystal structures, docking models, structure–activity relationship data, and Protein-ligand Structure Analysis can help identify which warhead positions tolerate substitution. Surface-exposed substituents are often more promising than deeply buried groups, but exposure alone is not enough. The direct attachment vector also determines where the degron sits relative to the target surface, which can strongly affect N-recognin access and target ubiquitination geometry.

A useful screening plan is to create several direct conjugates from different warhead exit vectors rather than placing all design confidence in one site. Two molecules can have nearly identical target affinity yet show very different degradation because the degron emerges from different sides of the bound target. For linker-free design, this vector effect can be larger than in more flexible systems.

Degron Identity and Degron-Switching Strategy

Degron identity determines which cellular recognition route is being tested. Proline can engage GID4-associated CTLH recognition, glycine can access CRL2^ZYG11B/ZER1 pathways, and basic or bulky hydrophobic N-terminal residues can be recognized through UBR-family N-recognins. The best choice depends on more than biochemical affinity. Expression of the recognition machinery, subcellular localization, target accessibility, and the final target–E3 orientation all matter.

For this reason, degron switching should be designed as a small matrix rather than a linear sequence of guesses. If two warhead attachment vectors are available, each can be paired with several degrons. This creates a focused set that tests both target geometry and E3 pathway. Activity patterns across the matrix can reveal whether failure is associated with one exit vector, one degron family, or the overall direct-conjugation concept.

Degron switching is also useful for mechanism confirmation. If degradation tracks with a specific N-recognin pathway and disappears when that pathway is disrupted, the result provides stronger support for the proposed mechanism than target loss alone.

Direct Attachment Site and Conjugation Chemistry

Direct conjugation chemistry must preserve both sides of the molecule. On the warhead side, modification should not destroy target binding. On the degron side, the recognition features required by the N-recognin should remain exposed. For many N-degron systems, masking the N-terminal amino group can severely alter recognition, so the synthesis route must be planned around the final free N terminus.

Amide formation is a practical way to connect an amino-acid carboxyl group to an appropriate warhead functionality while leaving the amino terminus available after deprotection. However, the most suitable chemistry depends on the functional groups present in the warhead and the desired orientation. Researchers should also monitor whether direct conjugation introduces additional ionizable groups, intramolecular hydrogen bonding, or conformational preferences that change solubility or permeability.

Matched controls are especially informative. A parent warhead establishes target-binding behavior without the degron. A direct conjugate tests the linker-free concept. A short-linker analog can show whether a small amount of separation helps or hurts activity. When resources allow, a longer conventional analog provides another reference point. This small matched series can answer the core question more efficiently than a large unsystematic linker library.

Stereochemistry Considerations in Direct Conjugates

Stereochemistry can influence degron recognition, warhead binding, and whole-molecule conformation. Because linker-free constructs are compact, a stereochemical change near the junction can alter the orientation of the degron relative to the target surface more directly than it might in a highly flexible molecule. The stereochemical configuration of the amino-acid degron should therefore be treated as a functional design variable, not as a purely synthetic detail.

Where the N-recognin has defined stereochemical preferences, the degron should preserve the configuration required for recognition. Matched stereoisomers can also serve as useful controls when they are expected to reduce E3 engagement without changing the target-binding portion of the molecule. Such controls help distinguish degradation that depends on a specific recognition event from nonspecific effects caused by the overall molecule.

Which E3 Ligase Pathways Are Relevant to Linker-Free PROTACs?

Three N-degron pathways have direct experimental support in amino acid-based degraders. Understanding how each recognizes its signal—and where each is expressed—tells you which options realistically exist for a given program.

Proline Degrons and GID4/CTLH Recruitment

GID4 is the substrate-recognition subunit of the CTLH (GID) E3 ligase complex. Structural work has shown that GID4 adopts a calycin-type β-barrel with a funnel-shaped binding tunnel. The free α-amino group of an N-terminal proline is anchored by acidic and polar residues at the top of the funnel, while proline's rigid aliphatic side chain docks into a small hydrophobic pocket—a snug, shape-selective interaction that explains why proline works so well as a compact degron. Flexible loops at the tunnel rim contact the residues immediately following the N-terminus, so the local sequence context around the conjugation site modestly influences affinity.

Beyond engineered degraders, GID4 has validated natural biology: it recognizes proline-starting degrons on metabolic enzymes such as HMGCS1, whose degradation is accelerated under nutrient stress, and on other cellular proteins identified through proximity labeling and chemical-probe experiments. This matters for two reasons. First, an existing substrate-processing pathway means the machinery is demonstrably capable of ubiquitinating GID4-delivered substrates in cells. Second, known endogenous substrates give program teams a set of positive-control benchmarks when setting up GID4-dependent degradation assays. For potency, the proline route remains the benchmark: Pro-BA's nanomolar DC₅₀ against EML4-ALK is the strongest degradation reported for any linker-free amino acid conjugate to date.

Glycine-Related Degrons and CRL2^ZYG11B/ZER1 Recruitment

N-terminal glycine is recognized by two related CRL2 complexes, CRL2^ZYG11B and CRL2^ZER1, which act redundantly in cells. The two adaptors differ in how they read the motif: ZYG11B's recognition footprint is small—essentially the terminal glycine plus the following residue—whereas ZER1 extends its contact surface three or more residues along the chain and favors downstream aromatic side chains. Because glycine has no side chain, recognition rests on backbone hydrogen bonds and the character of adjacent residues, which is why the residues immediately after the conjugation point deserve attention when a glycine degron underperforms.

The natural function of this pathway is quality control of protein N-myristoylation, a lipid modification that occurs exclusively on N-terminal glycine and normally shields the glycine from recognition. When myristoylation fails, the exposed glycine degron triggers proteasomal removal of the aberrant protein. Engineered glycine degraders simply bypass the lipid-cloaking step and present the glycine directly. In practice, Gly-BA degraded EML4-ALK with a DC₅₀ of 142 nM and initiated degradation faster than Pro-BA, making the glycine route a useful complement when rapid onset matters or when the proline pocket geometry of GID4 does not suit a particular attachment vector.

Basic and Hydrophobic N-Degrons Recognized by UBR Family Proteins

The UBR family contains the classical N-recognins—RING-type E3 ligases whose UBR boxes bind type 1 basic residues (Arg, Lys, His) and type 2 bulky hydrophobic residues (Phe, Trp, Tyr, Leu, Ile). This is the best-studied branch of the N-end rule, with rich structural and biochemical characterization. Yet it has proven the most difficult to exploit through direct single-amino-acid conjugation. Arg-BA required roughly 10 μM to degrade EML4-ALK, and lysine-based chimeras were the weakest performers among the amino acids tested in the AATac series.

The likely explanation is contextual. In natural substrates, basic and hydrophobic N-degrons often arise after proteolytic cleavage or post-translational modification—arginylation of oxidized cysteine, for example—and are presented within specific downstream sequence contexts that the UBR binding surface reads cooperatively. A single amino acid bolted onto an arbitrary exit vector may simply not reproduce that context. For program teams, the practical conclusion is not to avoid these degrons categorically, but to treat them as higher-risk, higher-information probes: if a UBR-recruiting conjugate works, it opens E3 biology that CRBN- and VHL-based programs cannot reach; if it does not, the Pro and Gly routes remain the proven options.

E3 Expression, Localization, and Target Compatibility as Selection Criteria

Choosing among these pathways is ultimately a question of matching E3 biology to target biology, and three criteria carry most of the weight. The first is expression: GID4/CTLH, ZYG11B/ZER1, and UBR proteins differ across tissues and cell lines, and a degrader can only work where its N-recognin is present. The second is localization: the E3 complex and the target must occupy compatible subcellular spaces long enough for ternary complex formation and ubiquitin transfer. The third is target compatibility: ubiquitination requires lysine residues on the target surface positioned within reach of the recruited ligase, and fusion proteins, truncated proteins, and multi-domain targets differ substantially in their usable lysine landscapes.

A pragmatic selection workflow therefore starts with bioinformatics-driven design: mining expression datasets for the N-recognins relevant to the intended cell models, inspecting target structures for exposed lysines near the warhead binding site, and ranking candidate degrons before the first flask is set up. Laboratory validation then proceeds in the relevant cellular background, using degron switching as the built-in cross-check. Teams that skip this matching step tend to rediscover it later as unexplained cell-line-dependent activity. Structured ligase system design support consolidates the same logic—E3 choice, expression screening, and compatibility assessment—into a defined decision framework.

Table 2. Amino Acid Degrons and Their Matching E3 Ligase Systems.

Read together, Table 2 and the pathway discussions above support a simple prioritization for new programs: start with proline, keep glycine as the rapid-onset alternative and mechanistic complement, and treat basic degrons as exploratory options to be justified by target-specific evidence rather than assumed to generalize.

Major Development Challenges and Solutions for Linker-Free PROTACs

Linker-free design simplifies one part of the molecule but increases the importance of every remaining interaction. The most common failure mode is not "the molecule is too short" in isolation. It is that the final direct conjugate cannot simultaneously satisfy target binding, degron recognition, productive target–E3 orientation, ubiquitination geometry, and cellular exposure. A problem-solving workflow should identify which of these factors is limiting before additional analogs are synthesized.

Degron Exposure and E3 Recognition Constraints

Challenge: The degron may be chemically present but poorly recognized. Direct attachment can place the amino acid too close to the target surface, shield the N terminus, alter local ionization, or create an intramolecular interaction that reduces accessibility to the N-recognin.

Solution: Preserve the recognition features known to be important for the selected pathway, especially the free N-terminal group when required. Compare alternative direct attachment vectors on the warhead. If a direct conjugate is inactive, a one- or two-atom junction change or very short spacer control can help determine whether the problem is steric exposure rather than the overall E3 concept. Binding or proximity assays with the E3-recognition component can provide an earlier answer than repeatedly measuring degradation alone.

Warhead Affinity Versus Direct-Conjugation Compatibility

Challenge: The highest-affinity warhead is not necessarily the best linker-free warhead. A ligand can bind tightly but expose only attachment vectors that point into the protein surface or toward a sterically crowded region. Direct modification can also reduce target affinity if the chosen substituent contributes to binding.

Solution: Rank warheads using both target affinity and geometry. Identify solvent-exposed positions from structural data, prepare a small set of exit-vector variants, and remeasure binding after degron installation. A moderate-affinity warhead with a favorable direct vector may outperform a stronger binder whose conjugation site creates an unproductive ternary arrangement. Where possible, compare binary affinity, ternary proximity, and degradation side by side rather than optimizing each in isolation.

Limited Generalizability Across Targets and Degron Classes

Challenge: The current experimental evidence for linker-free N-degron PROTACs is encouraging but still limited relative to the large body of conventional PROTAC research. A design that works for one kinase surface cannot be assumed to transfer to another target, even when the same degron and N-recognin are available.

Solution: Treat linker-free design as a hypothesis to test within a broader degrader program. Build matched direct-conjugate, short-linker, and conventional controls. Use degron switching to distinguish E3-pathway failure from target-geometry failure. If none of the direct constructs produces productive proximity, move to a short or conventional linker rather than forcing the linker-free format. The objective is efficient degradation, not architectural purity.

Balancing Compact Structure with Overall Developability

Challenge: Smaller does not automatically mean better. A linker-free molecule can still have low solubility, poor permeability, rapid metabolism, strong nonspecific binding, or an ionization profile that limits intracellular exposure. Degron selection itself can change charge and polarity.

Solution: Measure physicochemical behavior early. Solubility, stability, permeability, and cellular activity should be tracked alongside degradation potency. A PROTAC Cellular Permeability Assay can help determine whether weak cellular degradation reflects poor entry rather than poor ternary geometry. If compact analogs are active biochemically but weak in cells, property optimization may be more useful than additional E3 switching.

A practical decision tree is straightforward:

• If target binding is weak after conjugation, change the warhead attachment site or warhead scaffold.
• If target binding is retained but E3 engagement is weak, change degron identity or presentation.
• If both binary interactions are measurable but ternary proximity is poor, change the direct vector or introduce a minimal spacer control.
• If proximity is strong but ubiquitination is weak, investigate target orientation and accessible lysines.
• If biochemical activity is strong but cellular degradation is weak, investigate permeability, stability, and intracellular exposure.
• If degradation is strong but selectivity is uncertain, add proteome-level or targeted off-target evaluation before expanding the series.

Table 3. BOC Sciences Services for Linker-Free PROTAC Programs.

References

1. Zhang, Jianchao, et al. "Linker-Free PROTACs Efficiently Induce the Degradation of Oncoproteins." Nature Communications, vol. 16, Article 4794, 2025, https://www.nature.com/articles/s41467-025-60107-7
2. Timms, Richard T., et al. "A Glycine-Specific N-Degron Pathway Mediates the Quality Control of Protein N-Myristoylation." Science, vol. 365, no. 6448, 2019, eaaw4912, https://www.science.org/doi/10.1126/science.aaw4912
3. Chrustowicz, Jakub, et al. "Multifaceted N-Degron Recognition and Ubiquitylation by GID/CTLH E3 Ligases." Journal of Molecular Biology, vol. 434, no. 13, 2022, Article 167347, https://doi.org/10.1016/j.jmb.2021.167347
4. Tasaki, Takafumi, et al. "The N-End Rule Pathway." Annual Review of Biochemistry, vol. 81, 2012, pp. 261-289, https://www.annualreviews.org/doi/10.1146/annurev-biochem-051710-093308

Linker-Free PROTAC Development Support at BOC Sciences

BOC Sciences provides integrated products and services for amino acid-based degrader research, supporting teams from feasibility assessment and molecular design through custom synthesis, ternary complex and ubiquitination assays, and full physicochemical and biological evaluation of linker-free PROTAC candidates.

Linker-Free PROTAC Feasibility Assessment and Molecular Design

• Structure and mechanism analysis of PROTACs to evaluate exit vectors, degron exposure, and ternary complex plausibility before synthesis begins
• PROTACs targeting protein kinases and PROTAC solutions for non-small cell lung cancer research, covering the target classes where linker-free designs have been validated
• Degron panel planning (Pro/Gly/Lys/Arg and matched D-amino acid controls) with E3 expression and target lysine-landscape triage

Custom Degrader Synthesis and Focused Analog Libraries

• Synthesis of linker-free degraders and linker-bearing comparison sets from functionalized warheads and protected amino acid building blocks
• PROTAC libraries and linker libraries for building matched analog series and negative controls
• Small-molecule E3 ligase ligands and intermediates for programs that combine linker-free and conventional recruitment strategies

Ternary Complex, Ubiquitination, and Degradation Assays

• PROTAC activity assays reporting target engagement, degradation depth, and downstream pathway modulation in cellular systems
• Ligase engineering and production and custom protein expression and purification supplying N-recognin components such as GID4/CTLH for assay development
• Mechanism validation with proteasome inhibition, N-recognin knockdown, and ubiquitination readouts to confirm pathway dependence

Physicochemical and Biological Evaluation

• Permeability, solubility, plasma and chemical stability, and in vitro metabolism panels tailored to polar amino acid conjugates
• PROTAC in vivo animal model studies evaluating exposure, target degradation, and durability in disease-relevant models
• PROTAC delivery solutions and PROTAC research solutions for leukemia models supporting BCR-ABL and other fusion-protein programs

Explore featured products that can expand your research options and accelerate your next discovery.

Access end-to-end service solutions that help bring efficiency, flexibility, and expertise to your research pipeline.

News

• Protein Degradation with New Chemical Modalities: Successful Strategies in Drug Discovery and Chemical Biology
• Degrader Building Blocks for Targeted Protein Degradation
• Recent Progress of PROTACs Targeting Non-enzymatic Functional Proteins
• Discovery of Molecular Glue Degraders

Technical Information

• Proteolysis-Targeting Chimeras (PROTAC)
• Targeted Protein Degradation: The Next Frontier in Drug Discovery
• Overview of 12 Targeted Protein Degradation Technologies
• Peptide and Small Molecule Based PROTACs Technology